Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Powles

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
BMJ (Clinical Research Ed.)|March 14, 1992
Myeloma and benign intracranial hypertensionH Wasan, J L Mansi, S Benjamin, et al.
Blood|November 14, 1997
Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcomeJ Mehta, R Powles, J Treleaven, et al.
Pharmacoeconomics|September 5, 1995
Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infectionsA Stewart, R Powles, M Hewetson, et al.
Bone Marrow Transplantation|July 1, 1995
Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantationJ Mehta, R Powles, S Singhal, et al.
Bone Marrow Transplantation|December 1, 1995
Allogeneic bone marrow transplantation for primary myelofibrosisS Singhal, R Powles, J Treleaven, et al.
Medical and Pediatric Oncology|January 1, 1993
When is the optimum time to harvest peripheral blood stem cells in children following standard dose chemotherapy?J M Fernandez, V Shepherd, J Millar, et al.
Bone Marrow Transplantation|November 7, 2002
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaS Singhal, R Powles, B Sirohi, et al.
Leukemia & Lymphoma|June 1, 1997
Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantationJ Mehta, R Powles, S Singhal, et al.
Leukemia & Lymphoma|May 1, 1997
melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortalityP Hjiyiannakis, J Mehta, S Milan, et al.
Bone Marrow Transplantation|June 1, 1992
No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantationP Gupta, C Tiley, R Powles, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
BMJ (Clinical Research Ed.)|March 14, 1992
Myeloma and benign intracranial hypertensionH Wasan, J L Mansi, S Benjamin, et al.
Blood|November 14, 1997
Number of nucleated cells infused during allogeneic and autologous bone marrow transplantation: an important modifiable factor influencing outcomeJ Mehta, R Powles, J Treleaven, et al.
Pharmacoeconomics|September 5, 1995
Costs of antifungal prophylaxis after bone marrow transplantation. A model comparing oral fluconazole, liposomal amphotericin and oral polyenes as prophylaxis against oropharyngeal infectionsA Stewart, R Powles, M Hewetson, et al.
Bone Marrow Transplantation|July 1, 1995
Cytokine-mediated immunotherapy with or without donor leukocytes for poor-risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantationJ Mehta, R Powles, S Singhal, et al.
Bone Marrow Transplantation|December 1, 1995
Allogeneic bone marrow transplantation for primary myelofibrosisS Singhal, R Powles, J Treleaven, et al.
Medical and Pediatric Oncology|January 1, 1993
When is the optimum time to harvest peripheral blood stem cells in children following standard dose chemotherapy?J M Fernandez, V Shepherd, J Millar, et al.
Bone Marrow Transplantation|November 7, 2002
Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaS Singhal, R Powles, B Sirohi, et al.
Leukemia & Lymphoma|June 1, 1997
Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantationJ Mehta, R Powles, S Singhal, et al.
Leukemia & Lymphoma|May 1, 1997
melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortalityP Hjiyiannakis, J Mehta, S Milan, et al.
Bone Marrow Transplantation|June 1, 1992
No increase in relapse in patients with myeloid leukaemias receiving rhGM-CSF after allogeneic bone marrow transplantationP Gupta, C Tiley, R Powles, et al.
Pageof 20